Doximity Inc (Class A)

21 ago 2026, 19:36 UTC

Doximity shares are lower today despite Barclays raising its price target to $27 from $20, reflecting broader market pressures and uncertainty.

20 ago 2026, 19:16 UTC

Doximity Inc shares advanced during Thursday's session, reflecting a broader positive market trend and maintaining a position above the 20-day moving average.

19 ago 2026, 23:51 UTC

Doximity Inc shares are lower in after-market trading, with no specific news identified for the decline. The stock remains above its 20-day moving average.

18 ago 2026, 20:04 UTC

Doximity Inc. shares are higher, supported by a price target increase to $23.00 from Baird and a broader rally in Health Care Technology.

17 ago 2026, 20:02 UTC

Doximity Inc. reported first-quarter revenue of $156.62 million, but shares are declining despite guidance for second-quarter revenue of $170–171 million.

14 ago 2026, 20:02 UTC

Doximity Inc shares are lower today, continuing a significant decline since Thursday's close. Broader market sentiment is affected by a drop in U.S. retail sales.

13 ago 2026, 23:06 UTC

Doximity Inc shares are lower in after-market hours, reflecting a decline since Thursday's close. No specific news was identified to explain the movement.

12 ago 2026, 20:01 UTC

Doximity shares are declining amid negative sentiment from a sell recommendation, citing weak growth and rising costs. The stock is currently priced at $27.71.

11 ago 2026, 20:03 UTC

Doximity Inc reported Q2 revenue of $156.6 million, exceeding expectations. Shares are higher today amid strong demand for AI-powered clinical tools and positive market sentiment.

10 ago 2026, 23:36 UTC

Doximity Inc's shares are lower in after-market hours, with no specific news identified. Broader market conditions may be impacting investor sentiment.

7 ago 2026, 19:52 UTC

Doximity Inc's stock is higher after exceeding revenue expectations and raising its full-year sales outlook, despite a decline in net income.

6 ago 2026, 23:41 UTC

Doximity reported fiscal Q1 revenue of $156.6 million, exceeding expectations. The company raised its FY2027 revenue guidance, driving shares higher in after-hours trading.

5 ago 2026, 19:53 UTC

Doximity shares are lower ahead of Q2 earnings, with revenue growth projected to slow to 3.7%. ADP's jobs report adds to cautious market sentiment.

3 ago 2026, 20:02 UTC

Doximity Inc shares rise amid increased call activity and heightened implied volatility, despite mixed analyst ratings and a price target cut from Goldman Sachs.

31 jul 2026, 19:26 UTC

Doximity Inc shares are lower today amid broader market pressures and rising bond yields, reflecting investor sentiment in health care technology.

30 jul 2026, 19:29 UTC

Doximity Inc's shares are declining, continuing a downward trend since Wednesday. The stock remains below its 20-day moving average amid no specific news.

29 jul 2026, 18:43 UTC

Doximity Inc. shares are higher, supported by a significant rise in the Health Care Technology sub-sector and positive sentiment across correlated assets.

28 jul 2026, 18:36 UTC

Doximity Inc shares are advancing, supported by strong revenue growth and high gross margins. The stock reached a session peak earlier before pulling back slightly.

27 jul 2026, 18:03 UTC

Doximity shares are higher, supported by gains in the Health Care Technology sub-sector. Earlier, the stock pulled back from a session high.

24 jul 2026, 19:51 UTC

Doximity Inc. shares are lower, with first-quarter results showing modest declines and the stock trading below its 20-day moving average.

22 jul 2026, 14:33 UTC

Doximity Inc. shares are lower today amid a significant decline in the Health Care Technology sub-sector, trading below its 20-day moving average.

21 jul 2026, 18:13 UTC

Doximity Inc shares are lower today, driven by a decline in the Health Care Technology sub-sector and trading below the 20-day moving average.

20 jul 2026, 19:46 UTC

Doximity shares are advancing as Bank of America highlights OpenEvidence's $300 million revenue run rate and Doximity Ask's strong performance in an independent study.